JP Stock MarketDetailed Quotes

5868 Rococo

Watchlist

776
-12-1.52%

20min DelayMarket Closed Dec 16 15:18 JST

2.89BMarket Cap7.06P/E (Static)

Rococo Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

1.83B

1.94B

3.55%7.18B

1.85B

9.90%6.93B

6.3B

Cost of revenue

1.23B

1.24B

5.38%4.5B

1.16B

3.21%4.27B

4.14B

Gross profit

595.47M

697.76M

0.61%2.67B

687.51M

22.69%2.66B

2.16B

Operating expense

672.01M

575.15M

11.59%2.19B

601.21M

11.04%1.96B

1.77B

Operating profit

-76.54M

122.62M

-30.54%480.52M

86.31M

74.73%691.77M

395.91M

Net non-operating interest income (expenses)

-2.12M

-2.81M

-24.39%-18.42M

-8.41M

13.65%-14.81M

-17.15M

Non-operating interest income

--269K

--20K

-21.68%448K

--23K

-4.67%572K

--600K

Non-operating interest expense

--2.25M

--2.62M

-7.02%12.17M

--2.97M

-13.90%13.09M

--15.2M

Total other finance cost

--142K

--206K

192.07%6.7M

--5.46M

-10.04%2.29M

--2.55M

Net investment income

-7.04M

-7.61M

-685.24%-7.02M

2.85M

-30.17%1.2M

1.72M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-401K

Income from associates and other participating interests

Special income (charges)

6.97M

83.39%-2.7M

-101K

-435.18%-16.25M

-3.04M

Less:Other special charges

--0

---6.97M

-80.08%2.7M

--101K

346.38%13.55M

--3.04M

Less:Write off

----

--0

----

--2.7M

--0

Other non-operating income (expenses)

2.03M

5.1M

-120.55%-4.26M

-6.24M

-25.96%20.72M

27.99M

Income before tax

-83.67M

124.27M

-34.31%448.13M

74.41M

68.27%682.22M

405.43M

Income tax

-14.93M

43.84M

-30.74%158.67M

35.53M

177.12%229.09M

82.67M

Net income

-68.74M

80.42M

-36.12%289.46M

38.87M

40.39%453.14M

322.76M

Net income continuous operations

---68.74M

--80.43M

-36.12%289.46M

--38.87M

40.39%453.14M

--322.76M

Noncontrolling interests

-75.00%2K

Net income attributable to the company

-68.74M

80.42M

-36.12%289.46M

38.87M

40.40%453.13M

322.75M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-68.74M

80.42M

-36.12%289.46M

38.87M

40.40%453.13M

322.75M

Gross dividend payment

Basic earnings per share

-18.75

21.92

-36.90%109.9734

11.1066

89.00%174.2819

92.2143

Diluted earnings per share

-18.75

21.41

-36.90%109.9734

11.1066

89.00%174.2819

92.2143

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	1.83B	1.94B	3.55%7.18B	1.85B	9.90%6.93B	6.3B
Cost of revenue	1.23B	1.24B	5.38%4.5B	1.16B	3.21%4.27B	4.14B
Gross profit	595.47M	697.76M	0.61%2.67B	687.51M	22.69%2.66B	2.16B
Operating expense	672.01M	575.15M	11.59%2.19B	601.21M	11.04%1.96B	1.77B
Operating profit	-76.54M	122.62M	-30.54%480.52M	86.31M	74.73%691.77M	395.91M
Net non-operating interest income (expenses)	-2.12M	-2.81M	-24.39%-18.42M	-8.41M	13.65%-14.81M	-17.15M
Non-operating interest income	--269K	--20K	-21.68%448K	--23K	-4.67%572K	--600K
Non-operating interest expense	--2.25M	--2.62M	-7.02%12.17M	--2.97M	-13.90%13.09M	--15.2M
Total other finance cost	--142K	--206K	192.07%6.7M	--5.46M	-10.04%2.29M	--2.55M
Net investment income	-7.04M	-7.61M	-685.24%-7.02M	2.85M	-30.17%1.2M	1.72M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets			0		-401K	0
Income from associates and other participating interests
Special income (charges)	0	6.97M	83.39%-2.7M	-101K	-435.18%-16.25M	-3.04M
Less:Other special charges	--0	---6.97M	-80.08%2.7M	--101K	346.38%13.55M	--3.04M
Less:Write off	----	----	--0	----	--2.7M	--0
Other non-operating income (expenses)	2.03M	5.1M	-120.55%-4.26M	-6.24M	-25.96%20.72M	27.99M
Income before tax	-83.67M	124.27M	-34.31%448.13M	74.41M	68.27%682.22M	405.43M
Income tax	-14.93M	43.84M	-30.74%158.67M	35.53M	177.12%229.09M	82.67M
Net income	-68.74M	80.42M	-36.12%289.46M	38.87M	40.39%453.14M	322.76M
Net income continuous operations	---68.74M	--80.43M	-36.12%289.46M	--38.87M	40.39%453.14M	--322.76M
Noncontrolling interests	0	0	0	0	-75.00%2K	8K
Net income attributable to the company	-68.74M	80.42M	-36.12%289.46M	38.87M	40.40%453.13M	322.75M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0
Net income attributable to common stockholders	-68.74M	80.42M	-36.12%289.46M	38.87M	40.40%453.13M	322.75M
Gross dividend payment
Basic earnings per share	-18.75	21.92	-36.90%109.9734	11.1066	89.00%174.2819	92.2143
Diluted earnings per share	-18.75	21.41	-36.90%109.9734	11.1066	89.00%174.2819	92.2143
Dividend per share	0	0	20	20
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.